Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Treating obesity first to help with other conditions has been coined the obesity first approach
Clinical and Investigative Medicine 32 (1): E13-9
Telemedicine Licensing: Healthcare providers must be licensed in the state where the patient is located
For these patients, initiating weight loss injections may be considered if: The potential metabolic benefits (improved diabetes control, cardiovascular risk reduction, weight loss) substantially outweigh gallbladder risks Close monitoring is feasible with regular clinical follow-up Patients understand warning signs of gallbladder complications The rate of weight loss can be moderated through dosing strategies Conversely, patients with symptomatic gallstones experiencing biliary colic (right upper quadrant pain after meals), previous episodes of cholecystitis, or complications such as pancreatitisgenerally should undergo evaluation by a gastroenterologist or surgeon before starting weight loss injections
Tirzepatide is a dual GLP-1 + GIP receptor agonist
Probiotics After Metabolic and Bariatric Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
